Humulin M 70/30 is a medication used to treat diabetes and maintain healthy blood sugar levels. The drug is manufactured by Eli Lilly, a leading pharmaceutical company. The active substance in Humulin M 70/30 is a mixture of insulin and insulin isophane, and it comes in a convenient five-pen package that delivers 300 IU.
Insulin is a vital hormone produced by the pancreas that regulates blood sugar levels in the body. People with diabetes have a pancreas that either doesn’t produce enough insulin or doesn’t produce it at all, which can cause dangerous rises and falls in blood sugar levels. This can lead to a range of severe health problems, including blindness, kidney failure, and nerve damage.
Humulin M 70/30 is used to help manage these risks by supplementing the body’s natural insulin production with a combination of insulin and insulin isophane. Insulin is a fast-acting hormone that is designed to provide near-immediate relief to patients experiencing high levels of glucose in their bloodstream. Meanwhile, insulin isophane – sometimes called NPH – is a slow-acting insulin that provides longer-term glucose regulation.
The mixture of insulin and insulin isophane in Humulin M 70/30 provides patients with a more stable and consistent form of insulin than many other diabetic medications. Patients can administer the medication one to two times daily before mealtimes to help keep blood sugar levels under control.
Humulin M 70/30 comes in the form of a pen that delivers a premeasured dose of the medication with each injection. This delivery method is ideal for patients who need to administer their medication easily. The pens themselves are small, lightweight, and simple to use.
There are some risks associated with Humulin M 70/30, including the possibility of hypoglycemia or low blood sugar. Patients should monitor their blood sugar levels regularly and speak to their healthcare provider about adjusting their dosage if necessary. Other potential side effects include headache, dizziness, fatigue, and weight gain.
In conclusion, Humulin M 70/30 is an effective treatment option for patients with diabetes. Its combination of fast-acting insulin and slow-acting insulin isophane provide patients with a reliable way to regulate their blood sugar levels. The convenient pen delivery system and premeasured doses also make it easier for patients to stay on top of their medication regimen. Like any medication, however, it’s essential to speak to a healthcare provider about the medication’s proper use and associated risks.